Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 111 Records) |
| Query Trace: Neoplasms and meta-analysis and BRCA1[original query] |
|---|
| BRCA Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies. Medicina (Kaunas, Lithuania) 2021 9 57 (9): . Lee Yen-Chien, Lee Yen-Ling, Li Chung- |
| The preventive effect of breastfeeding against ovarian cancer in BRCA1 and BRCA2 mutation carriers: A systematic review and meta-analysis. Gynecologic oncology 2021 7 163 (1): 142-147. Eoh Kyung Jin, Park Eun Young, Chang Yoon Jung, Ha Hyeong In, Hong Juhye, Huang Dan, Nam Eun Ji, Lim Myong Che |
| Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 7 39 (23): 2617-2631. Casolino Raffaella, Paiella Salvatore, Azzolina Danila, Beer Philip A, Corbo Vincenzo, Lorenzoni Giulia, Gregori Dario, Golan Talia, Braconi Chiara, Froeling Fieke E M, Milella Michele, Scarpa Aldo, Pea Antonio, Malleo Giuseppe, Salvia Roberto, Bassi Claudio, Chang David K, Biankin Andrew |
| BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis. British journal of cancer 2021 12 126 (7): 1067-1081. Nyberg Tommy, Tischkowitz Marc, Antoniou Antonis |
| Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: a meta-analysis of observational studies. Carcinogenesis 2021 12 43 (3): 231-242. Park Junli, Huang Dan, Chang Yoon Jung, Lim Myong Cheol, Myung Seung-Kw |
| Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis. Breast (Edinburgh, Scotland) 2021 Sep 60 155-162. Gasparri Maria Luisa, Di Micco Rosa, Zuber Veronica, Taghavi Katayoun, Bianchini Giampaolo, Bellaminutti Serena, Meani Francesco, Graffeo Rossella, Candiani Massimo, Mueller Michael D, Papadia Andrea, Gentilini Oreste |
| A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Environmental and molecular mutagenesis 2022 Jul 63 (6): 308-316. Shao Changxia, Wan Jun, Lam Fred C, Tang Huilin, Marley Andrew R, Song Yiqing, Miller Chelsey, Brown Madeline, Han Jiali, Adeboyeje Gboye |
| A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer. Breast (Edinburgh, Scotland) 2022 Sep 66 31-39. Jia Xiaomeng, Wang Kainan, Xu Lingzhi, Li Ning, Zhao Zuowei, Li M |
| Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis. ESMO open 2022 8 7 (5): 100558. Gulia S, Kannan S, Ghosh J, Rath S, Maheshwari A, Gupta |
| Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer. Journal of the National Cancer Institute 2022 Aug . Kratz Christian P, Smirnov Dmitrii, Autry Robert, Jäger Natalie, Waszak Sebastian M, Großhennig Anika, Berutti Riccardo, Wendorff Mareike, Hainaut Pierre, Pfister Stefan M, Prokisch Holger, Ripperger Tim, Malkin Dav |
| Impact of homologous recombination deficiency biomarkers on outcomes in patients with early breast cancer: a systematic review protocol. BMJ open 2022 8 12 (8): e059538. Liao Hao, Pei Wendi, Zhong Jianxin, Li Huipi |
| A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer. Journal of oncology 2022 8 2022 5830475. Shao Changxia, Chang Michael S, Lam Fred C, Marley Andrew R, Tang Huilin, Song Yiqing, Miller Chelsey, Brown Madeline, Wan Isabella, Han Jiali, Adeboyeje Gboye |
| Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation. Cancers 2022 Jul 14 (13): . Pujol Pascal, Yauy Kevin, Coffy Amandine, Duforet-Frebourg Nicolas, Gabteni Sana, Daurès Jean-Pierre, Penault Llorca Frédérique, Thomas Frédéric, Hughes Kevin, Turnbull Clare, Galibert Virginie, Rideau Chloé, Corsini Carole, Collet Laetitia, You Benoit, Geneviève David, Philippe Nicol |
| High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer. The journal of pathology. Clinical research 2022 4 8 (4): 355-370. Aziz Diar, Lee Christine, Chin Venessa, Fernandez Kristine J, Phan Zoe, , , Waring Paul, Caldon C Elizabe |
| BRCA1 expression associated with the prognostic value of platinum-based chemotherapy for stage II-IV non-small cell lung cancer: A meta-analysis. The International journal of biological markers 2022 4 37 (2): 170-177. Huang Zhenhua, Xiong Ga |
| Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer. NPJ breast cancer 2022 4 8 (1): 43. Desnoyers A, Nadler M, Wilson B E, Stajer S, Amir |
| Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: a network meta-analysis. BMC cancer 2022 3 22 (1): 346. Suh Young Ju, Lee Banghyun, Kim Kidong, Jeong Yujin, Choi Hwa Yeon, Hwang Sung Ook, Kim Yong Be |
| Homologous Recombination Deficiency (HRD) and BRCA 1/2 Gene Mutation for Predicting the Effect of Platinum-Based Neoadjuvant Chemotherapy of Early-Stage Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis. Journal of personalized medicine 2022 2 12 (2): . Chai Yue, Chen Yujie, Zhang Di, Wei Yuce, Li Zhijun, Li Qiao, Xu Bing |
| The correlation of leukocyte-specific protein 1 (LSP1) rs3817198(T>C) polymorphism with breast cancer: A meta-analysis. Medicine 2022 11 101 (45): e31548. Chen Jian, Xiao Qiang, Li Xudong, Liu Ruihao, Long Xiaozhou, Liu Zhigao, Xiong Haiwei, Li Yinglia |
| PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology. Breast (Edinburgh, Scotland) 2022 11 66 293-304. Miglietta Federica, Cinquini Michela, Dieci Maria Vittoria, Cortesi Laura, Criscitiello Carmen, Montemurro Filippo, Del Mastro Lucia, Zambelli Alberto, Biganzoli Laura, Levaggi Alessia, Delle Piane Chiara, Marchiò Caterina, Calabrese Massimo, Fortunato Lucio, Franco Pierfrancesco, Meduri Bruno, Fittipaldo Veronica Andrea, Gori Stefan |
| Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case-Control Studies. Cancers 2022 Sep 14 (19): . Bara?ska Agnieszka, Kanadys Wies? |
| Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis. Gynecologic oncology 2023 8 177 72-85. Priyanka Narayan, Muhammad Danyal Ahsan, Emily M Webster, Luiza Perez, Sarah R Levi, Benedict Harvey, Isabel Wolfe, Shanice Beaumont, Jesse T Brewer, Drew Siegel, Charlene Thomas, Paul Christos, Andy Hickner, Eloise Chapman-Davis, Evelyn Cantillo, Kevin Holcomb, Ravi N Sharaf, Melissa K Fr |
| BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis. BMC cancer 2023 8 23 (1): 807. Zhewen Feng, Xiaobao Yang, Mingwei Tian, Na Zeng, Zhigang Bai, Wei Deng, Yanyan Zhao, Jianru Guo, Yingchi Yang, Zhongtao Zhang, Yun Ya |
| Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. Nature genetics 2023 8 . Naomi Wilcox, Martine Dumont, Anna González-Neira, Sara Carvalho, Charles Joly Beauparlant, Marco Crotti, Craig Luccarini, Penny Soucy, Stéphane Dubois, Rocio Nuñez-Torres, Guillermo Pita, Eugene J Gardner, Joe Dennis, M Rosario Alonso, Nuria Álvarez, Caroline Baynes, Annie Claude Collin-Deschesnes, Sylvie Desjardins, Heiko Becher, Sabine Behrens, Manjeet K Bolla, Jose E Castelao, Jenny Chang-Claude, Sten Cornelissen, Thilo Dörk, Christoph Engel, Manuela Gago-Dominguez, Pascal Guénel, Andreas Hadjisavvas, Eric Hahnen, Mikael Hartman, Belén Herráez, , Audrey Jung, Renske Keeman, Marion Kiechle, Jingmei Li, Maria A Loizidou, Michael Lush, Kyriaki Michailidou, Mihalis I Panayiotidis, Xueling Sim, Soo Hwang Teo, Jonathan P Tyrer, Lizet E van der Kolk, Cecilia Wahlström, Qin Wang, John R B Perry, Javier Benitez, Marjanka K Schmidt, Rita K Schmutzler, Paul D P Pharoah, Arnaud Droit, Alison M Dunning, Anders Kvist, Peter Devilee, Douglas F Easton, Jacques Sima |
| Expression of Concern: Bara?ska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case-Control Studies. Cancers 2022, 14, 4774. Cancers 2023 7 15 (14): . Cancers Editorial Offi |
| PARP Inhibitor Combinations in First Line mCRPC: A Systematic Review and Meta-Analysis. BJU international 2023 7 . Rashid K Sayyid, Zachary Klaassen, Alejandro Berlin, Soumyajit Roy, Leonardo R Brandão, Rui Bernardino, Julian Chavarriaga, Di Maria Jiang, Daniel E Spratt, Neil E Fleshner, Christopher J D Wall |
| Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis. Cancers 2023 5 15 (9): . Anna Amela Valsecchi, Rossana Dionisio, Olimpia Panepinto, Jessica Paparo, Andrea Palicelli, Francesca Vignani, Massimo Di Ma |
| Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis. Cancers 2023 3 15 (5): . Gaba Faiza, Blyuss Oleg, Tan Alex, Munblit Daniel, Oxley Samuel, Khan Khalid, Legood Rosa, Manchanda Ranj |
| BRCA1/2 pathogenic variants are not common in Merkel cell carcinoma: Comprehensive molecular study of 30 cases and meta-analysis of the literature. The Journal of investigative dermatology 2023 2 . Gaubert Alexandre, Kervarrec Thibault, Montaudié Henri, Burel-Vandenbos Fanny, Cardot-Leccia Nathalie, Di Mauro Ilaria, Fabas Thibault, Tallet Anne, Kubiniek Valérie, Pedeutour Florence, Dadone-Montaudié Bérengè |
| A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing. ESMO open 2023 2 8 (2): 100881. Paiella S, Azzolina D, Gregori D, Malleo G, Golan T, Simeone D M, Davis M B, Vacca P G, Crovetto A, Bassi C, Salvia R, Biankin A V, Casolino |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: